AUG 10, 2018 6:00 AM PDT

Cancer Cell 'Drones' Battle Immune System

WRITTEN BY: Caitlin Williams

Worldwide 8.8 million people die of cancer, that is almost 1 in 6 of all global deaths, and is the second leading cause of death globally. The most common cancers among men are lung, prostate, colorectal, stomach and liver while breast, colorectal, lung, cervix, and stomach cancer are most common among women. In all types of cancer, the body’s cells divide without stopping and spread to surrounding tissues. It can start almost anywhere in the human body and breaks up the orderly process of cell division and cell death. Cells become abnormal, old, and survive despite having damage, with new cells forming even if they are not needed. As cancerous cells continue to divide, they crowd out healthy cells and form growths called tumors, making it hard for the body to function correctly.  

Credit: The labs of Wei Guo, PhD, and Xiaowei Xu, MD, PhD, University of Pennsylvania.

Cancer cells suppress the immune system to allow tumors and cancerous cells to thrive and spread unchecked in the body. One of the most significant innovations in cancer therapy is checkpoint inhibitor drugs. These drugs block attempts by a cancer cell to suppress the immune system; a primary target is a T cell surface protein known as PD-1. Previous studies have found the PD-L1 protein on tumor cells interacts with the T cell counterpart PD-1 and turns off the T cell anti-cancer response. A recent study, published in Nature, shows that cancer cells combat the immune system by releasing the biological version of drones carrying PD-L1 to assist in the fight.

The researchers from the University of Pennsylvania showed small vesicles, known as exosomes, circulate the blood armed with PD-L1 proteins that cause T cells to tire before they even reach the tumor to do battle. This discovery of PD-L1 on exosomes provides a new outlook on the immune checkpoint mechanism and offers novel insight into tumor immune evasion. While the study focused on metastatic melanoma, they did find PD-L1-carrying exosomes secreted by breast and lung cancer cells as well. Dr. Wei Guo, one of the collaborators on the work, said: "We propose a model in which these exosomes act like drones to fight against T cells in circulation, even before the T cells get near to the tumor."

These findings may allow for a less invasive measure of monitoring cancer/T cell battle through blood tests versus invasive biopsies of tumors. Measuring levels of PD-L1 before treatment may allow for prediction of tumor burden in a patient and utilize the information to predict treatment outcome. After initial treatment, researchers can use a blood test for PD-L1 levels to monitor how well drugs are keeping cancer cells in check. Much like we measure sugar levels in diabetes patients, it is possible that PD-L1 monitoring, along with other biomarkers on the circulating exosomes, could be utilized as a way to keep tabs on treatments and patient response in a similar manner. These findings are another step toward precision and personalized medicine in cancer treatment.

To learn more about cancer cells, how they spread, and treatment options watch the video below!

American Cancer Society, National Cancer Institute 

 

About the Author
  • Caitlin holds a doctorate degree in Microbiology from the University of Georgia where she studied Mycoplasma pneumoniae and its glycan receptors. She received her Bachelor's in Biology from Virginia Tech (GO HOKIES!). She has a passion for science communication and STEM education with a goal to improve science literacy. She enjoys topics related to human health, with a particular soft spot for pathogens.
You May Also Like
FEB 10, 2021
Drug Discovery & Development
Black Men Respond Best to Immunotherapy for Prostate Cancer
FEB 10, 2021
Black Men Respond Best to Immunotherapy for Prostate Cancer
Researchers from Northwestern University have found that Black men and men of African ancestry respond better than men f ...
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
MAR 04, 2021
Immunology
Climate Change Tightens Its Grip on Hay Fever Sufferers
MAR 04, 2021
Climate Change Tightens Its Grip on Hay Fever Sufferers
There’s bad news for pollen allergy sufferers: New research has shown that climate change is making hay fever seas ...
MAR 25, 2021
Immunology
The Immune System Impairs Antibiotic Effectiveness
MAR 25, 2021
The Immune System Impairs Antibiotic Effectiveness
Nitric oxide, a molecule produced by the immune system, can negatively impact antibiotics’ effectiveness, says a s ...
MAR 30, 2021
Immunology
Single-Cell Technology Exposes Melanoma's Weak Spot
MAR 30, 2021
Single-Cell Technology Exposes Melanoma's Weak Spot
The immune system encompasses a powerful arsenal of weapons against pathogenic threats. But what stops healthy tissues i ...
MAY 17, 2021
Immunology
Understanding Inflammation: A Faster, Easier Way to Detect Cytokines in Cells
MAY 17, 2021
Understanding Inflammation: A Faster, Easier Way to Detect Cytokines in Cells
Inflammation, a process that was meant to defend our body from infection, has been found to contribute to a wide range o ...
Loading Comments...